Bullpen.News From Edwin Dorsey
Daily recap Feedback

Friday, September 4, 2026

Back to today

From X

@david_katunaric

Mikro Kap David on X

Yesterday I dug deeper into an 🇦🇺 special situation that reminds me of when I first found $ICCC back in September 2025. In both cases, a high-quality core business is taking share in an oligopolistic niche with a superior product, yet its underlying economics are obscured by a legacy development program that has consumed decades of spending and exhausted nearly everyone who has ever owned the stock. As was the case with ImmuCell, I don’t think this setup requires regulatory approval to work. FAA approval would create significant upside, while abandonment would remove the cost burden, allowing management to focus entirely on the core business and letting its underlying economics shine through. There is also a less “dramatic” but plausible third path: the legacy program’s drag on profitability continues to diminish while the attractive aerospace business grows around it. Both situations also brought experienced industry executives into senior leadership at a potentially important turning point. And, so far, I believe the new management team is making the right moves. There are several ways this could play out, but I believe the favorable outcomes are more likely, while the unfavorable ones shouldn’t carry much downside at the current valuation. I wrote up this company now so that, as new information emerges, you’ll know what matters, what doesn’t, and how each development changes the risk-reward. That should put you in a position to act while others are still parsing headlines and catching up. Link in the comment below.

Investor Letters

All letters

Sangamo Bankruptcy (SGMOQ)

Sangamo Therapeutics’ Chapter 11 asset sales leave common equity tied to $100 million in PTC Fabry therapy approval milestones and a…

SGMO $67M
Triple S Special Situations Investing 15 clicks

EVC Update

EVC reported a solid second quarter and outlook.

EVC $772M
Nat Stewart - Stock Picking Newsletter 25 clicks

IEH Corporation: Research Note

IEH Corporation won $6.5 million of APKWS orders, lifting backlog above $45 million as defense connector demand drives capacity expansion.

IEHC $80M
Atrium Research - Equity Research 2 clicks

Publications we follow

Every publication on this site, hand-picked.

69 publications

Newsletters 53

YouTube 4

Blogs 11

Seeking Alpha 14 of 110

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

55 accounts
Nominate an account

Sectors

Ordered by how often our editor reaches for them.